Cargando…
Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
Fibroblast growth factor receptor 2 (FGFR2) has two isoforms: IIIb type and IIIc type. Clinicopathologic significance of these two FGFR2 subtypes in gastric cancer remains to be known. This study aimed to clarify the clinicopathologic difference of FGFR2IIIb and/or FGFR2IIIc overexpression. A total...
Autores principales: | Yashiro, Masakazu, Kuroda, Kenji, Masuda, Go, Okuno, Tomohisa, Miki, Yuichiro, Yamamoto, Yurie, Sera, Tomohiro, Sugimoto, Atsushi, Kushiyama, Shuhei, Nishimura, Sadaaki, Togano, Shingo, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907198/ https://www.ncbi.nlm.nih.gov/pubmed/33633310 http://dx.doi.org/10.1038/s41598-021-84107-x |
Ejemplares similares
-
Gastric cancer stem cells survive in stress environments via their autophagy system
por: Togano, Shingo, et al.
Publicado: (2021) -
Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor
por: Kuroda, Kenji, et al.
Publicado: (2020) -
Establishment of a gastric cancer cell line with high microsatellite instability, OCUM‐13, derived from Borrmann type‐2 primary tumor
por: Yamamoto, Yurie, et al.
Publicado: (2022) -
Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer
por: Nishimura, Sadaaki, et al.
Publicado: (2022) -
Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer
por: Togano, Shingo, et al.
Publicado: (2020)